In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Alessandro SalustriDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.ORCID 0000-0002-8615-7265 Gioia CappellettiDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.ORCID 0000-0002-2932-2391 Flavio De MaioDepartment of Laboratory and Hematologic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168 Rome, Italy.ORCID 0000-0002-4744-9820 Youqing ShenZhejiang Key Laboratory of Smart Biomaterials, Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.
Filomena NuzziDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.
Ivana PalucciDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.ORCID 0000-0003-2106-1761 Francesco PaglioneDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.
Maurizio SanguinettiDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.ORCID 0000-0002-9780-7059 Michela SaliDepartment of Basic Biotechnological Sciences, Clinical, Intensive and Perioperative, Section of Microbiology, Catholic University of Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy.ORCID 0000-0003-3609-2990 Giovanni DeloguDepartment of Medicine and Surgery, Università degli Studi di Parma, Via Gramsci 14, 43126 Parma, Italy.
Funding
EU- MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases PE00000007, INF-ACT
6 · The paper itselfAbstract
Tuberculosis (TB) treatment is severely hampered by the rise in multi-drug-resistant strains and the prevalence of drug-induced toxicities. Host-Directed Therapies (HDTs) have emerged as a promising strategy to overcome these challenges by modulating innate immunity and circumventing
Indexed as
MacrophagesMycobacterium tuberculosisThioctic AcidTuberculosisAntitubercular AgentsApoptosisHost-Directed TherapyHumansPhagosomesTHP-1 CellsAntitubercular AgentsThioctic Acidhost-directed therapiesphagosome acidificationTHP-1 macrophagestuberculosisα-lipoic acid
Identifiers
PMID42278577
PMCPMC13256351
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390